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Abstract
Background: Worldwide nearly 3 million people die from chronic obstructive pulmonary disease (COPD) every year. Integrated
disease management (IDM) improves quality of life for COPD patients and can reduce hospitalization. Self-management of COPD
through eHealth is an effective method to improve IDM and clinical outcomes.
Objectives: The objective of this implementation study was to investigate the effect of 3 chronic obstructive pulmonary disease
eHealth programs applied in primary care on health status. The e-Vita COPD study compares different levels of integration of
Web-based self-management platforms in IDM in 3 primary care settings. Patient health status is examined using the Clinical
COPD Questionnaire (CCQ).
Methods: The parallel cohort design includes 3 levels of integration in IDM (groups 1, 2, 3) and randomization of 2 levels of
personal assistance for patients (group A, high assistance, group B, low assistance). Interrupted time series (ITS) design was used
to collect CCQ data at multiple time points before and after intervention, and multilevel linear regression modeling was used to
analyze CCQ data.
Results: Of the 702 invited patients, 215 (30.6%) registered to a platform. Of these, 82 participated in group 1 (high integration
IDM), 36 in group 1A (high assistance), and 46 in group 1B (low assistance); 96 participated in group 2 (medium integration
IDM), 44 in group 2A (high assistance) and 52 in group 2B (low assistance); also, 37 participated in group 3 (no integration
IDM). In the total group, no significant difference was found in change in CCQ trend (P=.334) before (–0.47% per month) and
after the intervention (–0.084% per month). Also, no significant difference was found in CCQ changes before versus after the
intervention between the groups with high versus low personal assistance. In all subgroups, there was no significant change in
the CCQ trend before and after the intervention (group 1A, P=.237; 1B, P=.991; 2A, P=.120; 2B, P=.166; 3, P=.945).
Conclusions: The e-Vita eHealth-supported COPD programs had no beneficial impact on the health status of COPD patients.
Also, no differences were found between the patient groups receiving different levels of personal assistance.
Trial Registration: Netherlands Trial Registry NTR4098; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4098
(Archived by WebCite at http://www.webcitation.org/6sbM5PayG)
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Introduction
Chronic obstructive pulmonary disease (COPD) is a slowly
progressive lung disease and a main cause of morbidity and
mortality in high-, middle-, and low-income countries [1].
Worldwide, nearly 3 million people die from COPD every year
which, in 2012, was equal to 6% of all deaths globally [2,3].
According to current COPD guidelines, symptoms and airflow
obstruction should be regularly monitored to modify treatment
and identify complications at an early stage [4,5]. Monitoring
should contribute to delaying disease progression and alleviate
its manifestations; the most important primary care objective
should be to improve quality of life (QoL) [6]. In primary care
COPD studies, the mean score on the Clinical COPD
Questionnaire (CCQ) reflects a mildly symptomatic COPD [7],
and the health status of patients was found to decline over a
longer period of time [8].
In the last decade, integrated disease management (IDM) was
introduced to improve quality of care. An IDM program consists
of different components of care in which different health care
providers are cooperating and collaborating to provide efficient
and good quality of care; IDM for COPD improves
disease-specific QoL and exercise capacity and also reduces
hospital admissions and hospital days per person [9].
To improve the quality and efficiency of IDM and reduce health
care costs, self-management of COPD patients was introduced
and has proven an effective method [10,11,12]. The core
components of self-management include education, eliciting
personalized goals, psychological coping strategies, improving
compliance to treatment, behavioral change, and practical and
social support [13,14]. Interventions to support self-management
have shown reductions in hospital admissions and fewer sick
days because of exacerbations [15,16]. Chronically ill patients
who received person-centered care focusing on patient activation
and goal setting are better self-managers [17], with self-efficacy
as an important factor influencing self-management behaviors
[18].
eHealth interventions are effective in stimulating
self-management in chronic disease; patients are better able to
cope with their illness and adapt their lifestyle, while eHealth
support also reduces medical staff consultations [19]. The
deployment of eHealth applications facilitates accessibility to
health care, enhances patient understanding of their disease,
sense of control, and willingness to engage in self-management
[20,21]. Although patient attitudes and receptiveness toward
eHealth applications are promising in certain groups of age and
education [22,23,24], large-scale adoption of eHealth in daily
practice still lags behind predictions in comparison with the
explosive growth of other digital tools like Facebook and Twitter
[25] (also, during recent years, online banking acceptance has
increased rapidly worldwide [26]). A major challenge of eHealth
in care coordination is to make it beneficial and easy to use for
both health care providers and patients [27]. It is important that
online self-management support is a fully integrated element
of IDM; COPD and asthma patients tended to use an online
application on a regular basis when the caregiver was involved,
whereas patients on their own used the application only
sporadically [28]. For clinicians, the eHealth evidence base
needs strengthening, while for primary care practices, a learning
process including staff training needs to be instituted [29]. Since
advances in eHealth are not clear for patients who have never
used it, it is necessary to provide patients with more and better
information about the possibilities and potential benefits of
eHealth to increase their self-efficacy and provide a feeling of
more personal control in daily life [30]. Furthermore, poor
user-friendliness of Web-based applications and the lack of
push factors (frequent reminders or messages by caregivers)
are a common cause of low usage or decline in usage [31].
Despite high expectations and numerous eHealth initiatives,
implementation and use of eHealth applications is not yet
common practice. Therefore, this e-Vita study investigated the
effect of usage of eHealth platforms on the health status of
COPD patients treated in primary care. In this paper, we describe
3 eHealth-supported care programs with different components
that support the treatment of COPD patients through digital
coaching. Two programs were applied as blended care (ie,
implemented within usual care to explore the potential for daily
health care practice), and one program was applied with the
self-management platform as an independent component.
In our e-Vita study, use of the self-management platforms was
higher when the platform was an integrated part of IDM and
with adequate personal assistance on how to use the platform
[32]. We hypothesize that use of the platforms will improve
self-management skills and thereby stabilize the health status
of COPD patients, with a greater effect with higher usage.
Methods
Study Design
Full methodological details of this multilevel parallel cohort
design have been reported previously [33]. For our
implementation study in a real-life health care setting, we used
an interrupted time series (ITS) design in a pragmatic trial in
which data were collected at multiple time points before and
after implementation to detect whether the intervention had a
significantly greater effect than any underlying secular trend
[34]. The ITS is performed according to the guidelines of the
Effective Practice and Organization of Care Cochrane review
group [35].
Figure 1 presents an overview of the study design. The study
included 3 different care groups in primary care (groups 1 to
3); all patients started using the Web-based platforms
(Multimedia Appendices 1 and 2).
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In groups 1 and 2, we offered the patients blended care, and in
group 3 the self-management platform was offered to the
patients as an independent module. In group 1, the online
platform was offered as a highly integrated part of the COPD
IDM (High) with a tailor-made intensive course program on
COPD for health care professionals that contained education
on COPD, training about the possibilities of eHealth, and
conversational techniques to approach patients in an equal and
coaching way. All patients in group 1 started with a personal
consultation with the primary care nurse with coaching on the
necessity of self-management and explanations of their burden
of disease and the eHealth program. Group 2 had a medium
level of integration (Medium) with a basic course program for
health care professionals on COPD that contained education on
COPD and training about the possibilities of eHealth. All
patients in group 2 started with a personal consultation with the
primary care nurse with coaching and explanation of the
self-management program. In groups 1 and 2, the first question
the nurse asked was what patients would like to achieve in their
daily life when they would have a lower burden of disease. With
the platform, the patients could work with a coaching program
on their personal goals, actions and health-related QoL [33]. In
group 3, the online platform was offered without integration in
COPD IDM (None); health care providers and patients received
basic instructions on the platform.
Two different levels of assistance for patients were distinguished
within groups 1 and 2: one with a high level of personal
assistance (A) and the other with a low level of personal
assistance (B). Patients were randomly subdivided into 2 groups.
In group 1A, high-level support implied home visits to patients
by a research nurse who coached and assisted in use of the
platform. In group 2A, high-level support implied telephone
consultation (3 times during the intervention period, scheduled
after 3, 6, and 9 months) between the patient and a research
nurse who explained use of the platform. In groups 1B and 2B,
low-level support implied that the primary care nurse showed
the patient only once how to use the platform. Patients in group
3 who used the online self-management platform had no support
from the caregivers or research nurses. Both platforms were
provided for the intervention period of 15 months.
Figure 1. Study design of the e-Vita online platform.
Participants
A total of 3 care groups participated. Patients were eligible when
they were diagnosed with COPD according to the Global
Initiative for Chronic Obstructive Lung Disease criteria
(post-bronchodilator FEV1/FVC <0.7) in accordance with the
COPD Guidelines of the Dutch College of General Practitioners
[36] and when they were being treated for COPD in primary
care. Patients were excluded if they were unable to fill in
questionnaires, had no access to the Internet, had a terminal
illness, were immobile, or were severe substance abusers.
Recruitment of Patients
We started by recruiting the care groups: managing general
practitioners (GPs) in groups 1, 2, and 3 decided to participate
because they wanted to contribute to possible health care
improvement. Members of the care groups (GPs) volunteered
to participate.
Patients were invited to participate by letter via their own GP.
When participants of the e-Vita study logged in and used the
Web platform at least once, they were defined as users. Patients
were defined as lost to follow-up if they did not log on to the
platform for at least 12 months after signing informed consent
or if they did not complete the digital questionnaires within the
intervention period.
Ethics Approval and Consent to Participate
This study was conducted according to the principles of the
Declaration of Helsinki (version 59, 2008) and in accordance
with the Medical Research Involving Human Subjects Act. The
study was approved by the Medical Ethics Committee of the
Medical University Center of Leiden. All subjects provided
written informed consent.
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The online self-management platforms were created by national
experts on chronic disease management guided by interviews
with COPD patients about their thoughts and feelings related
to living with COPD; the experiences of professional COPD
experts were also integrated. The main content of the platform
consists of insight into personal health data, self-monitoring of
health values (CCQ, Modified Medical Research Council
Dyspnea scale [MRC]), education, and a coach for attaining
personal goals. The educational and coaching programs were
developed by the Lung Alliance of the Netherlands. The online
self-management platform e-Vita is an initiative of the Dutch
foundation Care Within Reach [37]. The patients received
automated online reminders. Details on the online platforms are
published elsewhere [33].
Outcome Measures
The primary outcome is a clinical one, expressed as health status
(ie, the CCQ). This questionnaire was designed by Van der
Molen [38] and consists of 10 items, each answered on a 7-point
Likert scale. The CCQ comprises 3 domains: symptom state (4
items), functional state (4 items), and mental state (2 items).
The CCQ total score is calculated as the mean of the sum of all
items (minimum 0, maximum 6), with a higher value indicating
lower health status. The CCQ is a reliable and valid
questionnaire with a Cronbach alpha of 0.89-0.91.
Data collected at baseline included age, gender, education level,
and total scores on the CCQ, MRC [39], Generalized
Self-Efficacy Scale (GSES) [40], and EuroQol 5-dimension
questionnaire (EQ5D) [41]. Education was self-reported using
8 response categories ranging from no formal education to
graduate or professional level and converted into 3 levels (low,
medium, high). In the main analyses, personal assistance for
the participants (high assistance vs low assistance) and
integration in IDM (integrated vs not integrated) were used as
determinants.
Data Collection
Data were extracted from the log files of the self-management
platforms. Figure 2 shows the measurement schedule of the
CCQ. During the 15-month intervention period, there were 4
measurement periods with 3 CCQ questionnaires at each period
(3 data points before intervention and 9 data points after
intervention) in order to apply ITS analysis.
Figure 2. Interrupted time series measurements of the Clinical COPD Questionnaire per interval.
Sample Size Calculation
Generally, the health status of patients with COPD decreases
over time. Studies on IDM in COPD in primary care show that
a general increase in CCQ of 0.5 (SD 0.75) can be expected
over a 1-year period [42,43]. In this study, we offered patients
a Web platform in addition to their regular IDM program.
Therefore, we hypothesized that the regular increase in CCQ
(0.5 points per year) would change to stabilization of health
status as compared to literature [44].
To measure differences in health status (>0.5 CCQ points) at
80% power (SD 0.75 and α=0.05), 37 patients needed to be
included. Based on an estimated 20% drop-out during the study
period, 45 (37/0.80) patients needed to be included. As we used
2 different implementation methods (with and without personal
assistance) in 2 of the care groups, 2×45=90 patients needed to
be included in those groups. In the third care group, because
only 1 implementation method was used, a total of 45 patients
were required to achieve sufficient statistical power.
Statistical Methods
Categorical baseline characteristics were reported as numbers
and percentages, normally distributed continuous variables as
means with standard deviations (SD), and nonnormally
distributed variables as medians with interquartile ranges (IQRs).
Characteristics between the 3 groups were examined using
chi-square tests and Kruskal-Wallis tests.
ITS analyses were used to study time trends before and after
intervention. Due to the correlation between the repeated
measurements within a patient, we used multilevel linear
regression modeling (mixed models) to analyze CCQ data in
the total group as well as in the groups with high and low levels
of assistance and in the 5 subgroups.
The analyses allowed us to quantify the effect of the intervention
on CCQ versus the observed preintervention period. Estimates
for regression coefficients corresponding to 2 standardized effect
sizes were obtained: a direct change in the level of the CCQ
(also called step change or jump) and a change in trend of the
CCQ before and after the intervention [34].
Included in the model for the total group and 5 subgroups as
fixed effects were time, treatment, and the interaction between
time and treatment; the model comparing the groups with high
and low assistance additionally contained the assistance group
factor and the interaction of this factor. All models included a
random intercept per patient. When there was a substantial
improvement in the Akaike Information Criterion (used to assess
the model fit score), an additional random slope (time) was
used.
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Because of a nonnormal distribution of the CCQ data, the log
of the CCQ data was used as outcome in the multilevel linear
regression models. The analysis model did not test or correct
for seasonality; although seasonality influences exacerbations
of COPD, it has no effect on the CCQ [45,46]. We visually
assessed normality of the residuals to evaluate the validity of
the assumptions of the mixed models analysis.
Results
Inclusion
A total of 942 COPD patients were selected from 3 care groups
(Figure 3). The GPs of these care groups excluded 240 COPD
patients from participation due to other diseases, treatment in
hospital, or incompetency to participate in the program. Finally,
702 COPD patients were invited, of whom 215 (30.6%) agreed
and provided informed consent.
The number of patients lost to follow-up (no log on to the
platform after signing informed consent or not completing the
entire intervention period) was 132; results of the
nonparticipation analysis are reported elsewhere [33]. Figure 3
shows the reasons for loss to follow-up in groups 1 and 2;
patients in group 3 were not asked for their reasons.
Figure 3. Flowchart of the e-Vita chronic obstructive pulmonary disease study.
Baseline Characteristics of Patients With Chronic
Obstructive Pulmonary Disease
Table 1 presents the baseline demographic and clinical
characteristics of the included COPD population (median age
66.6 years; 52.1% male). These patients had mildly symptomatic
COPD which was reflected by a median MRC scale of 1.0 and
a median CCQ of 1.2. Out of 215 participants, 89 (41.4%) filled
in the online questionnaire for education level; most participants
had a middle education level, reflected by a 4 or 5 on a scale of
1 to 7 (38/89, 42.7%). The median GSES was 3.3, and the
median EQ-5D was 0.86. The characteristics age (χ22=5.4,
P=.07), education level (χ24=2.2, P=.70), GSES (χ
2
2=1.7, P=.42),
and EQ-5D (χ22=2.4, P=.28) were similar in the 3 groups. There
was a difference in the characteristic gender (χ22=6.8, P=.03),
with more male patients in group 1, and a difference in CCQ
(χ22=6.5, P=.04) and MRC scale (χ
2
2=11.3, P=.003), with a
higher CCQ and MRC scale in group 2.
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Table 1. Baseline characteristics of patients with chronic obstructive pulmonary disease in the e-Vita study.





















112 (52.1)20 (54.1)24 (46.2)17 (38.6)32 (69.6)19 (52.8)Males, n (%)
Education level, n (%)
32 (36.0)7 (53.8)8 (42.1)5 (22.7)8 (38.1)4 (28.6)Low
38 (42.7)4 (30.8)8 (42.1)11 (50.0)8 (38.1)7 (50.0)Medium
19 (21.3)2 (15.8)3 (15.8)6 (27.3)5 (23.8)3 (21.4)High
Questionnaire, median (IQR)
1.2 (0.8-1.9)1.3 (0.6-1.8)1.4 (1.1-2.1)1.3 (0.9-2.1)1.2 (0.8-1.6)1.0 (0.6-1.9)CCQb
1.0 (1.0-2.0)1.0 (1.0-1.0)2.0 (1.0-2.0)2.0 (1.0-3.0)1.0 (1.0-2.0)1.0 (1.0-3.0)MRCc













bCCQ: Clinical COPD Questionnaire.
cMRC: Modified Medical Research Council Dyspnea score.
dGSES: Generalized Self-Efficacy Scale.
eEQ-5D: EuroQoL 5-Dimension Questionnaire.
Health Status Changes
Figure 4 A shows the effect of the intervention on CCQ in the
total patient group. The decrease before the intervention was
0.5% per month and after the intervention 0.08% per month;
this difference was not significant (P=.334). The estimated direct
change in the level of the CCQ slopes at the moment of the
intervention (jump) was –0.015 (P=.421) implying that the CCQ
trend was 1.5% lower before the intervention.
Figure 4 B shows the effect of the intervention on CCQ in the
groups with a high level of personal assistance (A) and a low
level of personal assistance (B). In group A, the preintervention
decrease was 0.8% per month and the decrease after the
intervention was 0.05% per month; in group B, the
preintervention decrease was 1.8% per month and the decrease
after the intervention was 0.1% per month. No significant
difference was found in CCQ changes going from
preintervention to postintervention between groups A and B
(P=.429). The direct change in the level of the CCQ slopes at
the moment of the intervention (jump) was 0.017 in group A
and –0.033 in group B (implying that the CCQ trend was 1.7%
higher before the intervention in group A and 3.3% lower in
group B). There was no significant difference in the jumps
(P=.207).
Figure 4 C shows the effect of the intervention on the CCQ in
the 5 subgroups; no significant difference was found in the slope
of the CCQ before and after the intervention (1A, P=.237; 1B,
P=.991; 2A, P=.120; 2B, P=.166; 3, P=.945). The direct changes
in the level of the CCQ slopes before and after the intervention
(jump) were –0.0196 in group 1A, –0.0582 in group 1B, 0.0426
in group 2A, 0.0184 in group 2B, and –0.0874 in group 3 and
were not significant.
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Figure 4. (A) Total group analysis of health status, (B) analysis of health status in groups receiving high and low levels of assistance, and (C) subgroup
analyses of health status.
Discussion
Principal Findings
This study investigated the effect of use of eHealth platforms
on the health status of COPD patients in primary care. No
changes in health status were found before and after introduction
of the eHealth-supported COPD programs, and no differences
were found between care groups with a high versus a low level
of personal assistance.
It is essential to carefully review the design strategies for
integrating eHealth applications within disease management
[47] by means of a thorough evaluation and analysis of the
results. A recent study analyzed the effect of wearable devices
that monitored and provided feedback on physical activity
among young adults with obesity; providing a group with this
device resulted in less weight loss over 24 months [48]. In a
trial of elderly persons with a high risk for prehospitalization,
telemonitoring was offered for monitoring and reporting
symptoms but did not result in lower hospitalizations or
emergency room visits (although mortality was higher in this
telemonitoring group) [49]. High expectations of eHealth should
be preceded by evaluations in pragmatic studies on
implementation [50].
In our study, changes in health status CCQ were not within the
range of a minimal clinically important difference [51]. QoL
and health status are determined by a significant number of
factors [46]. We expect that eHealth interventions will be
effective in stimulating self-management and stabilizing health
status in COPD patients when these patients use the platforms
for a longer period of time. In earlier studies, a worsening in
health status was found for primary care patients over a longer
period of time [8]; this finding was not confirmed in our e-Vita
study. In Dutch primary care, the standards of IDM are high,
with a wide variety in the implementation of interventions [7];
this might explain the absence of a worsening of health status
before the intervention in our study. The introduction and
J Med Internet Res 2017 | vol. 19 | iss. 8 | e291 | p.7http://www.jmir.org/2017/8/e291/
(page number not for citation purposes)
Talboom-Kamp et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
integration of eHealth within IDM will not make a significant
difference in the short term due to the high standard of IDM.
In our study, the median baseline CCQ score of 1.2 was low
compared with scores in other primary care COPD studies,
which reflects mildly symptomatic COPD [7]. This limits the
room for stabilization or improvement in our primary outcome
(ie, ceiling effect).
In a patient population with more severe COPD (patient-data
meta-analysis from 2016), self-management interventions
improved health-related QoL at 12 months but not at 6 months
[52]; this confirms our observation that long-term use of
platforms is necessary for an effect on health status. In our
research, the platforms are probably not sufficiently customized
to the wishes or needs of COPD patients to provide sufficient
motivation to use the platform on a regular basis for a longer
period; in our e-Vita study, a significant number of users stopped
using the platforms (attrition) [32].
The change in level of CCQ (positive/negative) at the start of
the intervention might be explained by the participant rise in
consciousness regarding their health status, thereby completing
the questionnaire more critically after explanation from a health
care professional. Similar to our study, in a randomized
controlled trial (RCT) with asthma patients, the QoL was
enhanced over the first 3 months after starting to use a
self-management portal [53].
The effect of eHealth cannot easily be evaluated in a classical
RCT; integrating eHealth in IDM is a complex intervention in
a multidisciplinary care process. Pragmatic trials frequently
include complex interventions and often involve the skills and
experience of health care professionals [54] and are, therefore,
more suitable for eHealth studies.
EHealth technologies for chronic conditions can be used to
enhance self-management and revise the chronic care model;
patients who actively participate in their care achieve valuable
and sustained improvement in well-being [55,56]. Findings in
many eHealth studies suggest that the use of a personal health
record or self-management platform can promote an informed
or activated patient and augment the chronic care model for
self-management support and productive interactions even
though a direct dosage-effect relationship (usually analyzed in
a classical RCT) is not common in eHealth studies [57]. Also
in our e-Vita study, interpretation of the results on use and health
status cannot be made in a direct dosage-effect relationship. Use
of the self-management platform was higher when the platform
was an integrated part of IDM, with trained caregivers
encouraging patients to use the platform and with personal
assistance about how to use the platform, but without a
significant change in health status. Based on current literature
and the e-Vita COPD study, we conclude that eHealth-supported
self-management integrated into usual care can help patients
with COPD manage their disease better.
Further studies based on this study and current literature are
needed to establish the mechanisms most likely to ensure the
successful development and implementation of Web-based
self-management interventions, including considerations about
how the intervention is integrated in IDM and how it enhances
the patient’s self-management behavior to stimulate long-term
use of self-management platforms with a stabilizing effect on
health status [11,58].
Strengths and Limitations
This e-Vita COPD study has several strengths. To our
knowledge, it is the first to combine different study designs
thereby enabling simultaneous investigation of the effect of
eHealth and the effects of different organizational
implementation methods on health status. Randomization was
performed for the level of assistance provided to patients,
allowing comparison of patient groups with high and low levels
of assistance. Because the care groups 1, 2, and 3 were not
randomized, no analysis of the differences between these groups
can be made.
An advantage of the ITS design is that it detects changes that
are delayed or intermittent and can determine whether the change
is permanent or temporary. The design, including the 3
datapoints of CCQ before the intervention, also allows
evaluation of variables which are changing by comparing slopes
of trend lines before and after the intervention.
This study also has some limitations. Development of the
platforms was relatively difficult due to lack of experience in
this field. Also, decisions made during the design phase were
beyond the influence of our group but affected the usability of
the platforms. Self-management skills imply behavioral changes
which require some time, whereas the present study period was
restricted to 15 months. Furthermore, patients in a primary care
setting have a low burden of disease (in this study, a median
score on the CCQ of 1.2) and motivation to use the platform
might be negatively influenced by this fact. In respiratory
medicine there is a lack of research on patients with
mild-to-moderate COPD despite that over 80% of COPD
patients suffer from this stage of disease and are often treated
in primary care [59]. Other projects among care groups (eg,
patient education, start different IDMs) might influence the
speed and thoroughness of the implementation of our platforms.
This study also has limitations typically associated with eHealth
trials. For example, as GPs and patients were free to volunteer,
bias might have occurred in our study groups. Users were
self-selected and were, presumably, motivated to use the
Web-based platform as would be expected in a real-life setting.
Also, the patients selected to be invited by the GPs might differ
from other patient groups. Furthermore, GPs excluded 25.5%
of the COPD patients from this study. Of the 702 eligible
patients, 30.6% were willing to participate and provided
informed consent, and 61.4% of the participants dropped out
during follow-up. Even though the nonparticipants did not differ
in age or gender from the participants [32], caution is required
when generalizing these results to general practice.
Like most Internet outcome studies, there were 2 types of
attrition in our study; attrition from the intervention itself (lack
of site utilization) and attrition from the follow-up assessments.
This law of attrition (the phenomenon of participants stopping
usage) is a common finding in eHealth evaluations and one of
the fundamental and methodological challenges in the evaluation
of eHealth applications [60]. To prevent both types of attrition,
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email reminders were sent by the platform to fill in the
questionnaires. All users received urgent and repeated requests
to fill in questionnaires by email and by telephone. The attrition
curve was analyzed earlier and depicts the push factors that are
required to remind participants to use the platform [32]. The
loss to follow-up is high with a risk of biased results due to user
bias; therefore, these results are only applicable for users of
eHealth.
The study aimed to be inclusive rather than exclusive to achieve
higher external validity. Patients were excluded if they were
unable to fill in questionnaires, had no access to the Internet,
had a terminal illness, were immobile, or were severe substance
abusers. During the inclusion of patients, we found that patients
did not want to start the study for several different reasons: no
computer skills, old age, no problems with COPD, and other
reasons. These reasons are typical for eHealth research in a
primary care setting with a low burden of disease; participants
were self-selected and were, presumably, motivated to use the
Web-based platform as would be expected in a real-life setting.
Therefore, the results of the study are not generalizable to all
COPD patients but to those who are willing, motivated, and
able to use eHealth. Nevertheless, we believe that this study is
inclusive rather than exclusive, since there are almost no
limitations for participation for this group of motivated patients.
However, the practical applicability of our results for other
primary care groups is positive (ie, the study provides practical
insight into successful implementation of patient platforms).
Nevertheless, primary care organizations should take into
account the different aspects of the organization of blended care
and quality of implementation.
Although an RCT provides the most reliable evidence on the
effectiveness of interventions, this was not feasible for our
implementation study in a real-life health care setting with 3
different care groups. After randomization in groups 1 and 2,
more patients were assigned to the groups with a low level of
personal assistance (group 1B and 2B). After simple
randomization, some discrepancy between the numbers in the
comparison groups would be expected [61]. Such
unpredictability reflects the essence of randomness. Moreover,
the baseline characteristics did not differ significantly between
groups with high and low assistance. Therefore, we expect no
significant influence on the results.
To measure a significant difference in health status, 45 patients
were needed in each subgroup; although these numbers were
not met within each subgroup, analysis on the combined groups
should be sufficiently powered to detect relevant differences.
In addition, the number of data points collected before the
intervention has a substantial impact on the strength of an ITS
design. It is necessary to collect enough data points to be
convinced that a stable estimate of the underlying secular trend
has been obtained [62]. In our study, the 3 data points before
the intervention represent a minimum number of data and may
have influenced the effective power of our study.
Conclusion
There is growing interest in the potential of Web-based
self-management platforms to deliver more individually tailored
self-management support integrated into the everyday lives of
COPD patients to improve their quality of life. In this study,
the e-Vita eHealth-supported COPD programs had no significant
impact on the health status of COPD patients, health status
showed no significant change before or after the introduction
of the eHealth-supported programs, and no differences were
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